Yuko Shimizu‐Motohashi

Statistics

Publications

Citations

411

H-Index

Active since

2013

Affiliations

National Center of Neurology and Psychiatry(Current)

Tokyo National Hospital

University of Minnesota

Yuko Shimizu‐Motohashi is an author at National Center of Neurology and Psychiatry specializing in muscular dystrophy, medicine, and muscular dystrophy pathophysiology.

Publications per year

2013–2023

Publications

Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis

Norio Motohashi, Matthew S. Alexander, Yuko Shimizu‐Motohashi et al. · Journal of Cell Science · 2013 · 136 citations

Life Sciences, Molecular Biology, Molecular Genetics +17

Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials.

Yuko Shimizu‐Motohashi, Shouta Miyatake, Hirofumi Komaki et al. · PubMed · 2016 · 87 citations

Medicine, Molecular Genetics, Molecular Medicine +14

A phase I study of TAS‐205 in patients with Duchenne muscular dystrophy

Eri Takeshita, Hirofumi Komaki, Yuko Shimizu‐Motohashi et al. · Annals of Clinical and Translational Neurology · 2018 · 33 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Renal dysfunction can occur in advanced‐stage Duchenne muscular dystrophy

Takahiro Motoki, Yuko Shimizu‐Motohashi, Isao Saito et al. · Muscle & Nerve · 2019 · 30 citations

Medicine, Nephrology, Pediatric Nephrology +14

Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride

Hotake Takizawa, Yuko Hara–Azumi, Yoshitaka Mizobe et al. · Scientific Reports · 2019 · 28 citations · Full text

Medicine, Molecular Medicine, Pharmacology +16

1–5 of 10